158 related articles for article (PubMed ID: 22692862)
1. Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databases.
Jong MC; Jong MU; Baars EW
Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1295-301. PubMed ID: 22692862
[TBL] [Abstract][Full Text] [Related]
2. Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases.
Jong MC; van Wietmarschen H; Glockmann A; Baars EW; Hamre HJ
Drugs Real World Outcomes; 2021 Dec; 8(4):589-601. PubMed ID: 34322827
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006.
Lapeyre-Mestre M; Grolleau S; Montastruc JL;
Fundam Clin Pharmacol; 2013 Apr; 27(2):223-30. PubMed ID: 21929527
[TBL] [Abstract][Full Text] [Related]
4. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
Durrieu G; Olivier P; Bagheri H; Montastruc JL;
Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
[TBL] [Abstract][Full Text] [Related]
5. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
[TBL] [Abstract][Full Text] [Related]
6. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.
Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A
Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453
[TBL] [Abstract][Full Text] [Related]
7. Gadobutrol for contrast-enhanced magnetic resonance imaging in elderly patients: review of the safety profile from clinical trial, post-marketing surveillance, and pharmacovigilance data.
Endrikat J; Schwenke C; Prince MR
Clin Radiol; 2015 Jul; 70(7):743-51. PubMed ID: 25933719
[TBL] [Abstract][Full Text] [Related]
8. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
[TBL] [Abstract][Full Text] [Related]
10. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacovigilance of vaccines].
Autret-Leca E; Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F
Arch Pediatr; 2006 Feb; 13(2):175-80. PubMed ID: 16343870
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
13. Methodologies for the detection of adverse drug reactions: comparison of hospital databases, chart review and spontaneous reporting.
Miguel A; Azevedo LF; Lopes F; Freitas A; Pereira AC
Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):98-102. PubMed ID: 23027707
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.
Rottenkolber D; Schmiedl S; Rottenkolber M; Farker K; Saljé K; Mueller S; Hippius M; Thuermann PA; Hasford J;
Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):626-34. PubMed ID: 21384463
[TBL] [Abstract][Full Text] [Related]
15. European Union directives and their effect on the registration and authorisation of anthroposophic and homeopathic medicines.
Laso LR; Alfonso-Galán MT
Med Law; 2009 Mar; 28(2):269-82. PubMed ID: 19705642
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of etifoxine: A French pharmacovigilance survey.
Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T
Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database.
Conforti A; Opri S; D'Incau P; Sottosanti L; Moretti U; Ferrazin F; Leone R
Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):597-602. PubMed ID: 22337264
[TBL] [Abstract][Full Text] [Related]
19. Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data.
Solomon C; Gröner A; Ye J; Pendrak I
Thromb Haemost; 2015 Apr; 113(4):759-71. PubMed ID: 25502954
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced blood consumption: the impact of adverse drug reactions on demand for blood components in German departments of internal medicine.
Rottenkolber D; Schmiedl S; Rottenkolber M; Thuermann PA; Hasford J
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):240-7. PubMed ID: 22487717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
